NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/05/2026
Voltar para busca
Dado oficial do USPTO
AMESOPAX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AMESOPAX
ST13
US500000079365161Classe
1, 5, 42, 44
Pedido
79365161
Registro
7470204
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
15/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
07/12/2022
Data de registro
13/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/08/2024
Última transação
15/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
28
Localização do titular
DD
Examinador
CERDA, VICTOR
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
RHEACELL GmbH & Co. KG
Representantes
Sean K. Owens Wood Herron & Evans LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Stem cells for scientific use; stem cells for research use; cell growth media for growing cells for scientific use; stem cells other than for medical or veterinary purposesstem cells for aesthetic purposes excluding all medical or veterinary purposes
Classe 5
Drugs for medical purposespharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparationspharmaceutical preparations for treating skin disorders; diagnostic agentsdiagnostic radiopharmaceutical agent for use in PET imaging; pharmaceutical preparationspharmaceutical preparations for treating skin disorders; preparations for medical purposespharmaceutical preparations for treating skin disorders; preparations for biomedical purposespharmaceutical preparations for treating skin disorders; pharmaceutical cell preparations for treating skin disorders; substances for medical usepharmaceutical preparations for treating skin disorders; substances for biomedical purposespharmaceutical preparations for treating skin disorders; live implants for pharmaceutical purposesimplants comprising living tissue for pharmaceutical purposes; biochemical and chemical products for medical usepharmaceutical preparations for treating skin disorders; biochemical and chemical products for pharmaceutical purposespharmaceutical preparations for treating skin disorders; biochemical and chemical diagnostic preparations for medical purposes; proteins for medical purposesprotein arrays for medical diagnosis purposes; biological preparations for medical and veterinary purposespharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparations for external and systemic usepharmaceutical preparations for treating skin wounds; biologicalpharmaceutical and veterinary preparations for skin care for medical purposespharmaceutical preparations for treating skin disorders; medical dressings; preparations for wound treating and healingpharmaceutical preparations for treating skin wounds; pharmaceutical preparations for treating skin wounds; stem cells for medical purposes; stem cells for veterinary purposes; somatic stem cell therapeuticssomatic stem cells for medical or veterinary use; cells for medical use in the nature of fibroblasts for medical purposes; cells for medical use in the nature of fibroblasts for surgical beauty purposes; pharmaceutical implantsimplantable pharmaceutical preparations for treating cancer; cells for medical use in the nature of surgical implants derived from stem cells; cells for medical use in the nature of surgical implants derived from fibroblasts; cells for medical use in the nature of biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissueliving cells for medical use; biotechnologically engineered tissue productscells for medical use
Classe 42
Pharmaceutical drug development; scientific and technological servicesscientific research in the field of genetics; research and development services in the fields of cell diagnosticscell therapy; scientific research for medical purposes in the field of genetics; stem cell research services; scientific research; scientific research and development; scientific researchtesting and analysis services in the field of genetics; medical research; biomedical research services; research and development in the field of biotechnology; research and development in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development of new products; industrial process researchresearch and development of new products; research and development of new products for the pharmaceutical industry; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information about medical and scientific research for pharmaceutical products; preparation of reports relating to scientific research
Classe 44
Medical services; medical diagnostic testingmonitoring and reporting services; medical assistance; health clinic services; hospital services; plastic and cosmetic surgery; medical therapiesproviding laser therapy for treating medical conditions; medical services in the field of regenerative medicine; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/02/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/02/2025
FIMP
FINAL DISPOSITION PROCESSED
03/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
13/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/05/2024
PUBO
PUBLISHED FOR OPPOSITION
28/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/04/2024
RFNT
REFUSAL PROCESSED BY IB
13/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/10/2023
RFRR
REFUSAL PROCESSED BY MPU
24/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/10/2023
CNRT
NON-FINAL ACTION WRITTEN
12/10/2023
DOCK
ASSIGNED TO EXAMINER
13/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AMESOPAX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.